SLC7A5 expression was found to be associated with significantly lower 5-year survival rates in SLC7A5-positive lung cancer patients than in SLC7A5-negative ones, which might be associated with tumor proliferation, angiogenesis, and a poor prognosis [65,66]. Here, SLC7A5 is linked to lung carcinoma.